Efficacy and Safety of Belimumab in Patients With Lupus Nephritis: Subgroup Analyses of a Phase 3 Randomized Trial in the East Asian Population.

Xueqing Yu,Nan Chen,Jun Xue,Chi Chiu Mok,Sang-Cheol Bae,Xiaomei Peng,Wei Chen,Hong Ren,Xiao Li,Kajohnsak Noppakun, Jennifer A Gilbride,Yulia Green,Beulah Ji,Chang Liu,Anuradha Madan,Mohamed Okily,Chun-Hang Tang,David A Roth

American journal of kidney diseases : the official journal of the National Kidney Foundation（2022）

引用 5|浏览15

暂无评分

摘要

Safety and efficacy profiles were consistent with BLISS-LN overall population, supporting benefits of belimumab treatment in the East Asian population with LN.

查看译文

关键词

Belimumab,glomerulonephritis,lupus nephritis,lymphocytes,proteinuria,renal responses,systemic lupus erythematosus

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要